Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
800 Clinicopathological and molecular predictive factors of survival in non-small cell lung cancer patients treated with first-line immunotherapy with or without chemotherapy: a systematic review and meta-analysis
Compose a Response to This Article
Other responses
No responses have been published for this article.